As detailed in this section, CNTN1 antibodies have been implicated in peripheral demyelinating neuropathies, while CNTN2 antibodies have been detected in a small subset of multiple sclerosos (MS) patients. The gene discussed is CNTN2; the disease is myeloid sarcoma.